Charles Bennett to Aged
This is a "connection" page, showing publications Charles Bennett has written about Aged.
Connection Strength
1.832
-
The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions. Oncologist. 2021 08; 26(8):e1418-e1426.
Score: 0.061
-
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.
Score: 0.058
-
Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors. Cancer Med. 2019 05; 8(5):2233-2240.
Score: 0.053
-
What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening? Clin Genitourin Cancer. 2017 12; 15(6):e977-e985.
Score: 0.046
-
Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. J Clin Oncol. 2017 Jun 10; 35(17):1945-1951.
Score: 0.046
-
Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. Br J Haematol. 2018 01; 180(2):301-304.
Score: 0.044
-
Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system. Expert Opin Drug Saf. 2016 Aug; 15(8):1003-11.
Score: 0.044
-
Time course and predictors of use of erectile dysfunction treatment in a Veterans Affairs medical center. Int J Impot Res. 2016 Sep; 28(5):167-71.
Score: 0.043
-
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016 Feb; 51(2):277-82.
Score: 0.042
-
Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system. Expert Opin Drug Saf. 2015; 14(11):1653-60.
Score: 0.041
-
Screening for viral hepatitis prior to rituximab chemotherapy. Ann Hematol. 2016 Jan; 95(1):27-33.
Score: 0.041
-
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer. 2014 Aug 15; 120(16):2464-71.
Score: 0.038
-
Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. 2013 Apr; 131(4):499-506.
Score: 0.035
-
Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study. J Clin Oncol. 2010 May 20; 28(15):2571-6.
Score: 0.028
-
Metastasis of genitourinary tumors to the head and neck region. Eur Arch Otorhinolaryngol. 2010 Feb; 267(2):273-9.
Score: 0.027
-
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 May 14; 113(20):4834-40.
Score: 0.026
-
Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. 2009 Feb; 47(2):176-83.
Score: 0.026
-
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008 Sep 15; 113(6):1446-52.
Score: 0.026
-
Late-onset hereditary axonal neuropathies. Neurology. 2008 Jul 01; 71(1):14-20.
Score: 0.025
-
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. 2007 Sep 18; 50(12):1138-43.
Score: 0.024
-
Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. 2007 Aug; 12(8):1019-26.
Score: 0.024
-
Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. 2007 Jul; 8(3):273-81.
Score: 0.023
-
Cost considerations in the management of cancer in the older patient. Oncology (Williston Park). 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim.
Score: 0.023
-
Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. 2007 Apr; 12(4):478-83.
Score: 0.023
-
Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. 2007 Feb; 131(2):489-96.
Score: 0.023
-
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006 Jul; 68(1):89-93.
Score: 0.022
-
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. 2005 Dec 01; 23(34):8877-83.
Score: 0.021
-
Pure red-cell aplasia and epoetin therapy. N Engl J Med. 2004 Sep 30; 351(14):1403-8.
Score: 0.019
-
Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004 Sep 01; 22(17):3524-30.
Score: 0.019
-
Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. 2004 Jul 01; 22(13):2617-22.
Score: 0.019
-
Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004 Jun; 3(1):31-7.
Score: 0.019
-
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004 May-Jun; 2(3):271-8.
Score: 0.019
-
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecol Oncol. 2004 Apr; 93(1):164-9.
Score: 0.019
-
HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
Score: 0.019
-
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. 2004 Feb; 35(2):533-7.
Score: 0.018
-
Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. 2003 Dec 01; 37(11):1549-55.
Score: 0.018
-
Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer. Crit Rev Oncol Hematol. 2003 Oct 15; 48(Suppl):S71-4.
Score: 0.018
-
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making? Drugs Aging. 2003; 20(7):479-83.
Score: 0.017
-
Medicare Spending on Drugs With Accelerated Approval. Ann Intern Med. 2022 07; 175(7):938-944.
Score: 0.016
-
Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform. 2021 May; 28(1).
Score: 0.015
-
Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol. 2000 Aug; 18(15):2805-10.
Score: 0.015
-
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000 Jun 15; 342(24):1773-7.
Score: 0.014
-
Operation Safe Haven: an evaluation of health surveillance and monitoring in an acute setting. Commun Dis Intell. 2000 Feb 17; 24(2):21-6.
Score: 0.014
-
Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis. Cancer Causes Control. 2020 Mar; 31(3):209-220.
Score: 0.014
-
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology. Ann Oncol. 1999 Nov; 10(11):1355-9.
Score: 0.014
-
Preparing for refugee crises in Australia: Kosovar health surveillance. Commun Dis Intell. 1999 Oct 28; 23(11):305.
Score: 0.014
-
Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res. 1999 Aug; 8(5):461-70.
Score: 0.014
-
Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg. 1999 Jun; 188(6):604-22.
Score: 0.013
-
A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res. 1999 May; 8(3):171-80.
Score: 0.013
-
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Ann Oncol. 1999 Feb; 10(2):177-82.
Score: 0.013
-
A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct; 37(10):2099-2108.
Score: 0.013
-
Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest. 1999; 17(8):559-65.
Score: 0.013
-
Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol. 1998 Nov; 160(5):1765-9.
Score: 0.013
-
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998 Sep; 16(9):3101-4.
Score: 0.013
-
Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making. 1998 Jul-Sep; 18(3):278-86.
Score: 0.013
-
Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer. Clin Genitourin Cancer. 2018 08; 16(4):313-317.
Score: 0.013
-
Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998 Apr 01; 128(7):541-4.
Score: 0.012
-
Cancer insurance policies in Japan and the United States. West J Med. 1998 Jan; 168(1):17-22.
Score: 0.012
-
Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions. Transfusion. 2017 08; 57(8):2045-2053.
Score: 0.012
-
Gender differences in early suspicion of tuberculosis in hospitalized, high-risk patients during 4 epidemic years, 1987 to 1990. Infect Control Hosp Epidemiol. 1997 Apr; 18(4):237-43.
Score: 0.012
-
Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. Urology. 1997 Feb; 49(2):218-24.
Score: 0.011
-
Economic analyses of phase III cooperative cancer group clinical trials: are they feasible? Cancer Invest. 1997; 15(3):227-36.
Score: 0.011
-
Western impressions of the Hong Kong health care system. West J Med. 1996 Jul-Aug; 165(1-2):37-42.
Score: 0.011
-
Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years. J Oncol Pract. 2016 06; 12(6):e670-80.
Score: 0.011
-
Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Sep; 51(9):1228-32.
Score: 0.011
-
Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. 2015 Oct; 55(10):2321-30.
Score: 0.010
-
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. 2015 Jul; 26(7):1390-5.
Score: 0.010
-
Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology. 1995 Apr; 45(4):633-40.
Score: 0.010
-
Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Rep. 1995 Mar-Apr; 110(2):166-72.
Score: 0.010
-
Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). 2015 Apr; 24(4):291-8.
Score: 0.010
-
Informal caregivers of persons with AIDS. J Palliat Care. 1995; 11(2):10-8.
Score: 0.010
-
The association between race and treatment regret among men with recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2015 Mar; 18(1):38-42.
Score: 0.010
-
Racial differences in cervical cancer mortality in Chicago. Am J Public Health. 1994 Jun; 84(6):1007-9.
Score: 0.009
-
Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. 2014 Mar-Apr; 12(2):121-7.
Score: 0.009
-
Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):134-43.
Score: 0.009
-
Improving colon cancer screening in community clinics. Cancer. 2013 Nov 01; 119(21):3879-86.
Score: 0.009
-
Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. 2013 Aug; 31(8):1669-75.
Score: 0.009
-
Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. 2013 Jul; 53(7):773-8.
Score: 0.009
-
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. 2014 Jan; 32(1):26.e25-31.
Score: 0.009
-
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. 2013 Jan; 81(1):130-4.
Score: 0.009
-
Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1992; 5(9):856-64.
Score: 0.008
-
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. 2012 Jul; 110(2):201-5.
Score: 0.008
-
Patterns of care related to age of men with prostate cancer. Cancer. 1991 May 15; 67(10):2633-41.
Score: 0.008
-
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010 Sep; 95(9):1555-62.
Score: 0.007
-
Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needs. J Palliat Med. 2010 Feb; 13(2):161-9.
Score: 0.007
-
Evaluation of a potential clinical interaction between ceftriaxone and calcium. Antimicrob Agents Chemother. 2010 Apr; 54(4):1534-40.
Score: 0.007
-
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. Urology. 2010 Mar; 75(3):623-9.
Score: 0.007
-
Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack. Intern Med J. 2010 Apr; 40(4):275-80.
Score: 0.007
-
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
Score: 0.007
-
Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008 Mar 01; 27(5):412-21.
Score: 0.006
-
Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007 Nov; 45(11):1026-33.
Score: 0.006
-
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
Score: 0.006
-
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. 2007 Jun; 137(6):545-52.
Score: 0.006
-
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
Score: 0.006
-
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9.
Score: 0.006
-
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst. 2007 Feb 07; 99(3):196-205.
Score: 0.006
-
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep. 1986 Sep; 70(9):1081-4.
Score: 0.006
-
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006 Aug; 21(8):847-51.
Score: 0.006
-
Staging and therapy of orbital lymphomas. Cancer. 1986 Mar 15; 57(6):1204-8.
Score: 0.005
-
Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005 May; 79(5):1698-703.
Score: 0.005
-
Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. 2005 Apr; 2(2):A11.
Score: 0.005
-
Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. 2004 Dec; 3(12):1298-303.
Score: 0.005
-
Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
Score: 0.005
-
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
Score: 0.005
-
Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997. Eur J Cancer. 2003 May; 39(7):961-7.
Score: 0.004
-
Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. 2003 Feb; 15(2):60-2.
Score: 0.004
-
Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 2003 Jan; 61(1):172-8.
Score: 0.004
-
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. 2002 Sep; 1(2):105-14.
Score: 0.004
-
IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000 Jul; 164(1):214-8.
Score: 0.004
-
Comparative study of the clinical efficacy of two dosing regimens of flutamide. Mol Urol. 2000; 4(3):259-63;discussion 265.
Score: 0.003
-
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
Score: 0.003
-
QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Williston Park). 1999 Jun; 13(6):823-32; discussion 835-8.
Score: 0.003
-
Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol. 1998 Dec; 71(3):369-75.
Score: 0.003
-
Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc. 1998 Jan; 73(1):5-9.
Score: 0.003
-
Comparison of perspectives on prostate cancer: analyses of survey data. Urology. 1997 Sep; 50(3):366-72.
Score: 0.003
-
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med. 1996 Oct; 11(10):591-6.
Score: 0.003
-
Evaluation of two AIDS education programs for impoverished Latina women. AIDS Educ Prev. 1994 Aug; 6(4):296-309.
Score: 0.002
-
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. AIDS Res Hum Retroviruses. 1993 Oct; 9(10):1043-50.
Score: 0.002
-
Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1993 Jun; 6(6):617-23.
Score: 0.002
-
Role of granulocyte-macrophage colony stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease. Anticancer Drugs. 1993 May; 4 Suppl 1:13-6.
Score: 0.002
-
AIDS-related knowledge, perceptions, and behaviors among impoverished minority women. Am J Public Health. 1993 Jan; 83(1):65-71.
Score: 0.002
-
Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk adjustment approach. J Clin Epidemiol. 1989; 42(5):421-5.
Score: 0.002